NL-OMON42438尚未招募不适用
Towards the development of neo-antigen-targeted, personalized immunotherapies for advanced colorectal cancer patients. - Neo-antigen targeting in advancer colorectal cancer patients.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Tumors analysed will be derived from CRC patients diagnosed with high-risk stage II (IIC), stage III and IV colorectal cancers.
- •At least 20% of the patients participating in the study should be individuals diagnosed with colorectal cancer until de age of 50 years-old.
排除标准
- •Severe anemia (Hb < 6.0 mmol/L)
研究者
相似试验
招募中
不适用
Study for development of new treatment for antibody mediated rejection in organ transplantatioorgan failureJPRN-UMIN000030525Tokyo Women's Medical University41
Unknown
不适用
Feasibility 'innate' allogeneic stem cells transplantioHematological malignancies (hematologische maligniteiten)Allogeneic stem cells transplantation (allogene stamcel transplantatie)Innate immune system (aangeboren immuunsysteem)NL-OMON25484MC UtrechtHeidelberglaan 1003584 CX Utrecht35
招募中
1 期
Personalized neoantigen peptide vaccine for advanced solid canceradvanced-stage non-small cell lung cancer (NSCLC),colorectal cancer (CRC),pancreatic cancer and melanomaNeoantigen peptide vaccine,Immunotherapy,Metastatic cancerTCTR20191003001Chulalongkorn University35
招募中
不适用
Development of new approaches for immunotherapy of non-small cell lung cancerC34Malignant neoplasm of bronchus and lungDRKS00029641Molekulare PneumologieUniversitätsklinikum Erlangen
Unknown
1 期
Neo-MASCT Immunotherapy for Advanced NSCLC.NSCLC Stage IVNCT03205930The First People's Hospital of Lianyungang20